(Total Views: 227)
Posted On: 06/11/2021 8:55:49 AM
Post# of 46
$BIO News Article - Ryvu Therapeutics Presents Positive Phase I Data for RVU120 at the Virtual 26th Annual Congress of the European Hematology Association. Phase I/II Data for SEL24 (MEN1703) presented by development partner Menarini https://marketwirenews.com/news-releases/ryvu...27550.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
